- 2024/04/16We exhibited a booth and gave an oral presentation at the 23rd Annual Meeting of the Japan Society for Regenerative Medicine.
- 2024/03/21[New Product] Completion of Development and Launch of TPO Alternative Peptide(TPOR agonist)
- 2024/01/09Publication of Application Data for Alveolar Organoid Generation Using PG-004
- 2023/12/01[New Product] Launch of Synthetic EGF
- 2023/11/29PeptiGrowth participated the CiRA symposium and gave a presentation
- 2023/11/14[New Product] Completion of Development and Launch of Wnt3a Alternative Peptide (β-catenin pathway agonist)
- 2023/11/07PeptiGrowth exhibited a booth and gave a presentation at Cell UK
- 2023/10/15Attended and presented at ISCCM2023
- 2023/10/11Participated in Cell and Gene Meeting on the Mesa
- 2023/10/11We had the exhibition booth at Regenerative Medicine Japan 2023
- 2023/09/05[New Product] Completion of Development and Launch of VEGF Alternative Peptide (VEGFR2 Agonist)
- 2023/08/22Joint Development of Novel Synthetic Peptide Based Growth Factor with Orizuru Therapeutics Inc.
- 2023/06/29The start of selling PG peptides at Tebubio
- 2023/05/23The start of selling PG peptides at Scientist.com and Stratech. 2023/05/23
- 2023/04/27Webinar：We made a presentation at the webinar organized by Good Food Institute(GFI).
- 2023/04/07Webinar: We held a webinar on Scientist.com.
- 2023/02/01A New article contribution to YODOSHA, “Experimental Medicine”, Special Issue. Title:’ Development of synthetic peptide growth factor and their future perspective’
- 2022/12/08New Products Release – BMP7 selective inhibitor and BMP4 selective inhibitor
- 2022/10/11New article in Nature – “A growing market for synthetically produced peptides”
- 2022/10/05PeptiGrowth exhibit Regenerative Medicine JAPAN and hold a mini-seminar (December 12-14, 2022)
